CFIV

NASDAQ

CF Acquisition Corp. IV

SectorFinanceIndustryBlank ChecksIPO2021

News25/Ratings0

CF Acquisition Corp. IV does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the financial services, healthcare, real estate, technology, and software industries. The company was incorporated in 2020 and is based in New York, New York.

Latest news

25 items

799d13D/G
SEC Form SC 13G/A filed by CF Acquisition Corp. IV (Amendment)
SC 13G/A - CF ACQUISITION CORP. IV (0001825249) (Subject)
805d13D/G
SEC Form SC 13G/A filed by CF Acquisition Corp. IV (Amendment)
SC 13G/A - CF ACQUISITION CORP. IV (0001825249) (Subject)
857dSEC
SEC Form 15-12G filed by CF Acquisition Corp. IV
15-12G - CF ACQUISITION CORP. IV (0001825249) (Filer)
868dSEC
SEC Form 25-NSE filed by CF Acquisition Corp. IV
25-NSE - CF ACQUISITION CORP. IV (0001825249) (Subject)
877dSEC
CF Acquisition Corp. IV filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
8-K - CF ACQUISITION CORP. IV (0001825249) (Filer)
877dNEWS
CF Acquisition Corp. IV Announces Its Intention To Liquidate; Wll Not Make Next $150,000 Monthly Installment Due By Nov. 28 to Its Trust Account; Will Cease All Operations Except For Purpose Of winding Up; Redeem Public Shares; Dissolve And Liquidate
877dPR
CF Acquisition Corp. IV Announces its Intention to Liquidate
NEW YORK, Nov. 28, 2023 /PRNewswire/ -- CF Acquisition Corp. IV (NASDAQ:CFIV) ("CF IV"), a publicly traded special purpose acquisition company, today announced that its board of directors (the "Board") has determined to redeem all of its outstanding shares of Class A common stock, par value $0.0001 per share ("Class A common stock"), sold in its initial public offering (the "public shares") because CF IV is unlikely to be able to complete an initial business combination by the deadline under its Amended and Restated Certificate of Incorporation, as amended. Accordingly, CF IV
892dSEC
SEC Form 10-Q filed by CF Acquisition Corp. IV
10-Q - CF ACQUISITION CORP. IV (0001825249) (Filer)
898dNEWS
Why Alteryx Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Gainers Senti Biosciences, Inc. (NASDAQ:SNTI) shares surged 120.8% to $0.6450 in pre-market trading after the company reported a new strategic collaboration with Celest Therapeutics for the clinical development of SENTI-301A in China. Tharimmune, Inc. (NASDAQ:THAR) shares rose 76.8% to $0.2790 in pre-market trading as the company disclosed the execution of an exclusive worldwide licensing agreement with Avior Inc. d/b/a Avior Bio, LLC to develop, market and commercialize a clinical-stage asset, AV104. TransMedics Group, Inc. (NASDAQ:TMDX) shares rose 39.7% to $56.16 in pre-market trading after the company reported better-than-expected third-quarter sales results and issued strong FY23 r
958dSEC
CF Acquisition Corp. IV filed SEC Form 8-K: Leadership Update
8-K - CF ACQUISITION CORP. IV (0001825249) (Filer)
983dSEC
SEC Form 10-Q filed by CF Acquisition Corp. IV
10-Q - CF ACQUISITION CORP. IV (0001825249) (Filer)
1031dSEC
CF Acquisition Corp. IV filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
8-K - CF ACQUISITION CORP. IV (0001825249) (Filer)
1045dSEC
SEC Form DEFA14A filed by CF Acquisition Corp. IV
DEFA14A - CF ACQUISITION CORP. IV (0001825249) (Filer)
1045dINSIDER
SEC Form 4 filed by Cfac Holdings Iv, Llc
4 - CF ACQUISITION CORP. IV (0001825249) (Issuer)
1045dSEC
CF Acquisition Corp. IV filed SEC Form 8-K: Unregistered Sales of Equity Securities, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
8-K - CF ACQUISITION CORP. IV (0001825249) (Filer)
1046d13D/G
SEC Form SC 13G/A filed by CF Acquisition Corp. IV (Amendment)
SC 13G/A - CF ACQUISITION CORP. IV (0001825249) (Subject)
1051dPR
CF Acquisition Corp. IV Announces That its Trust Account Will Not Be Decreased Due to Excise Tax
NEW YORK, June 7, 2023 /PRNewswire/ -- CF Acquisition Corp. IV (NASDAQ: CFIV) (the "Company") today announced that, to mitigate the current uncertainty surrounding the implementation of the Inflation Reduction Act of 2022, in the event that the extension (the "Extension") of the time period the Company has to complete an initial business combination (the "Business Combination") is implemented, as described in the proxy statement filed by the Company on May 22, 2023 (the "Proxy Statement"), in connection with its special meeting of stockholders to be held on June 22, 2023 (the "Meeting"), CFAC Holdings IV, LLC (the "Sponsor"), the sponsor of the Company, or a designee, will indemnify the Comp
1067dSEC
SEC Form DEF 14A filed by CF Acquisition Corp. IV
DEF 14A - CF ACQUISITION CORP. IV (0001825249) (Filer)
1074dSEC
SEC Form 10-Q filed by CF Acquisition Corp. IV
10-Q - CF ACQUISITION CORP. IV (0001825249) (Filer)
1087dSEC
SEC Form PRE 14A filed by CF Acquisition Corp. IV
PRE 14A - CF ACQUISITION CORP. IV (0001825249) (Filer)
1119dSEC
SEC Form 10-K filed by CF Acquisition Corp. IV
10-K - CF ACQUISITION CORP. IV (0001825249) (Filer)
1199d13D/G
SEC Form SC 13G filed by CF Acquisition Corp. IV
SC 13G - CF ACQUISITION CORP. IV (0001825249) (Subject)
1206d13D/G
SEC Form SC 13G filed by CF Acquisition Corp. IV
SC 13G - CF ACQUISITION CORP. IV (0001825249) (Subject)
1211dSEC
CF Acquisition Corp. IV filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
8-K - CF ACQUISITION CORP. IV (0001825249) (Filer)
1219dSEC
SEC Form DEFA14A filed by CF Acquisition Corp. IV
DEFA14A - CF ACQUISITION CORP. IV (0001825249) (Filer)